AIMC Topic: Crizotinib

Clear Filters Showing 1 to 2 of 2 articles

Explainable artificial intelligence for precision medicine in acute myeloid leukemia.

Frontiers in immunology
Artificial intelligence (AI) can unveil novel personalized treatments based on drug screening and whole-exome sequencing experiments (WES). However, the concept of "black box" in AI limits the potential of this approach to be translated into the clin...

Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects.

Nature communications
We present comboFM, a machine learning framework for predicting the responses of drug combinations in pre-clinical studies, such as those based on cell lines or patient-derived cells. comboFM models the cell context-specific drug interactions through...